Postdischarge-to-30-Day Mortality Among Patients Receiving MitraClip: A Systematic Review and Meta-Analysis

Postdischarge-to-30-Day Mortality Among Patients Receiving MitraClip: A Systematic Review and Meta-Analysis

Background: MitraClip (MC) implantation is the recommended treatment for severe symptomatic mitral regurgitation in patients not responding to medical therapy and at prohibitive surgical risk. It is important to quantify immediate mortality during postdischarge-to-30-day period so as to improve the...

Full description

Bibliographic Details
Main Authors: Beni R. Verma, MD, Shashank Shekhar, MD, Toshiaki Isogai, MD, Raghuram Chava, MD, Pejman Raeisi-Giglou, DO, Agam Bansal, MD, Shameer Khubber, MD, Bryce Montane, MD, Prashansha Vaidya, MD, Simrat Kaur, MD, Manpreet Kaur, MD, Rhonda Miyasaka, MD, Serge C. Harb, MD, Amar Krishnaswamy, MD, Samir R. Kapadia, MD
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Structural Heart
Subjects:
Heart failure
Mitral valve disease
Mortality
Percutaneous valve therapy
Structural heart disease intervention
Online Access:http://www.sciencedirect.com/science/article/pii/S2474870622012611

Internet

http://www.sciencedirect.com/science/article/pii/S2474870622012611

Similar Items